Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Philadelphia, Pennsylvania 19107


Purpose:

The purpose of this study is to observe the incidence of nausea with systemic chemotherapy that includes consecutive days (more than one day)of cisplatin medication.


Study summary:

Questionnaires are completed on week of chemotherapy treatment referred to as Dartmouth regimen.


Criteria:

Inclusion Criteria: - confirmed diagnosis metastatic melanoma - 18 years and older - undergoing chemotherapy with Dartmouth regimen - medically stable to receive chemotherapy per physical and clinical laboratory tests Exclusion Criteria: - No medical conditions that interfere with assessment of nausea and vomiting during chemotherapy - No cognitive disorder that impairs symptom assessment - No other investigational agent - Inability to swallow medications for nausea and vomiting - No gastric outlet obstruction


NCT ID:

NCT00716560


Primary Contact:

Principal Investigator
Takami Sato, M.D.,Ph.D.
Thomas Jefferson University


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19107
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.